EditCo

EditCo Bio

[EditCo @EditCo_Bio]

Announcing our newest edited-to-order primary cells: Knockout CD8+ T-cell Pools!! With high post-editing viability and proven cytotoxicity, customizable CRISPR solutions of the future are here. 🚀💥

https://t.co/7l910Nbiwg

#TcellEditing #CRISPR #EditCoBio #GenomeEngineering

[EditCo @EditCo_Bio]

New POLG paper shows mtDNA synthesis + OxPhos rescue in mutant patient cells using a small-molecule activator👉https://t.co/XBg05PCwv0
iPSCs developed at @EditCo_Bio(formerly Synthego). High-quality #iPSCs make results like this possible👉https://t.co/fvXzshkZj5 #DiseaseModeling

[EditCo @EditCo_Bio]

Fresh year, fresh edits. May your 2026 be high-efficiency, low-noise, and publication-ready!

Happy New Year from the EditCo team!

#CRISPR #GeneEditing #CellEngineering #GenomeEditing #Hello2026

[EditCo @EditCo_Bio]

This year brought big milestones for @EditCo_Bio, and we reached every one of them together. From growing our portfolio and partnerships to advancing disease modeling and drug discovery, we’re grateful for everyone who made 2025 unforgettable. Here’s to 2026! #Hello2026 #CRISPR

[EditCo @EditCo_Bio]

As we close out 2025, we’re grateful for a year of collaboration & progress. Together with scientists, researchers, partners, distributors & investors, EditCo advanced CRISPR-enabled cell engineering:rapid, precise, scalable & high-value. Thank you for being part of the journey🎉

[EditCo @EditCo_Bio]

Before the year winds down, take a fresh look at your CRISPR data❄️ICE Analysis helps you quickly interpret editing efficiency & outcomes, so you can head into the holidays with clarity & confidence. Always on, always ready to help decode CRISPR edits👉https://t.co/tEAz3pFDHG

[EditCo @EditCo_Bio]

CRISPR-edited pools or clonal lines, what do you really need? High-efficiency KO pools can be fast & cost-effective. But for knock-ins, essential genes, or long-term studies, clonal lines offer the confidence pools can’t. Read more in Cell Engineering 101👉https://t.co/Ofi5EX15lS

[EditCo @EditCo_Bio]

Is your iPSC truly pluripotent? Proper pluripotency testing is critical for reliable models. Our latest editorial breaks down key assays & best practices to ensure high-quality cells & more reliable disease models👉
https://t.co/onHxGkj86i
#iPSC #StemCells #Pluripotency #Biotech

[EditCo @EditCo_Bio]

CRISPR workflows vary, and so do your cell model options.
See how XDel knockouts compare with single-guide cells & KO libraries to support different research needs. If you need fast, high-efficiency knockouts with consistent results, XDel Cells stand out👉https://t.co/iLAw06zlAi

[EditCo @EditCo_Bio]

Achieving reliable CRISPR knock-ins used to be a challenge. Our on-demand webinar walks through the data behind >80% knock-in rates, improved consistency, and scalable edited pools and clones. Watch now👉
https://t.co/b18AVQ03As
#CRISPR #HiBiT #CellEngineering #DrugDiscovery

[EditCo @EditCo_Bio]

CRISPR efficiency depends on cell health. If cells aren’t in good shape, even the best tools struggle.
@EditCo_Bio + IDEXX BioAnalytics break down why cell fitness matters and how to optimize it. Watch the webinar👉 https://t.co/1Z8RIGa7U8 #CRISPR #CellHealth #GeneEditing

[EditCo @EditCo_Bio]

CRISPR is reshaping cancer target discovery. This on-demand symposium highlights: SURF2 as a new therapeutic target with XDel, AI-driven synthetic lethal discovery & Streamlined CRISPR workflows for oncology. Watch now 👉 https://t.co/1ClDr4LThg #Oncology #CRISPR #CancerResearch

[EditCo @EditCo_Bio]

🎁Give the gift of faster CRISPR workflows! With @EditCo_Bio’s Referral Program: Your colleague gets 50% off GKO Kits or 15% off XDel Knockouts. You get 15% off your next order. Simple. Helpful. Scientific. Refer a colleague today👉https://t.co/Dl1ZIaQkuT #CRISPR #GeneEditing

[EditCo @EditCo_Bio]

The HPRT 6-TG assay makes knockout validation clear: parental iPSCs die, HPRT KO cells survive, a clean functional readout for gene loss. @EditCo_Bio delivers high-efficiency KO iPSC pools & clones with optimized CRISPR workflows👉 https://t.co/eiHqsYh9r5 #CRISPR #iPSCells

[EditCo @EditCo_Bio]

Did you see? Roche’s new success clearing amyloid plaques is boosting momentum in Alzheimer’s research. Our CRISPR iPSCs power NIH’s large-scale Alzheimer’s effort, enabling scalable, disease-relevant models for faster discovery👉 https://t.co/jKU4KNoUQT #Alzheimers #CRISPR

[EditCo @EditCo_Bio]

Save up to $1,000 on your next CRISPR knockout with EditCo’s XDel Cell Engineering Service! Achieve fast, consistent knockouts powered by multi-guide RNA technology & rigorous QC, trusted across 1400+ engineered cell lines. Use promo code NewECXDEL2025👉https://t.co/oVxl09gdp6

[EditCo @EditCo_Bio]

Celebrating the scientists pushing discovery forward, one cell at a time 🦃🥂🍽️

#CRISPR #GeneEditing #XDel #BiotechResearch #CellEngineering #CellBiology #happythanksgiving

[EditCo @EditCo_Bio]

Have you checked out our CRISPR-edited T cells in action?
>90% editing efficiency. Essential function intact. Real tumor-killing results.
Watch the video and see how knockout pools accelerate cancer and cell therapy research👉https://t.co/ZMKzq5FcKT
#TCells #CRISPR #immunology

[EditCo @EditCo_Bio]

Exciting news! @EditCo_Bio just launched Referral Program. Share your code → friends get 50% off GKO Kits or 15% off XDel Knockouts → you get 15% off your next order. Start sharing now👉 https://t.co/IxX7vaXOE6 #CRISPR #GeneEditing #MolecularBiology #ResearchTools #CellBiology

[EditCo @EditCo_Bio]

As Neuroscience 2025 wraps up, a good reminder: iPSC editing only works when the genome is stable. Even small chromosomal changes can shape neural assay results. Karyotyping helps confirm integrity before cells move into complex neuro models👉 https://t.co/pyqt1atFw8

[EditCo @EditCo_Bio]

Stop optimizing. Start discovering. Skip months of troubleshooting w/ ready-to-use, reproducible XDel knockouts & save big: $500 off Pools | $1000 off Clones (for new XDel customers, limited time) Use code NewECXDEL2025 w/ your EditCo rep or in the form👉https://t.co/gD595YhcAB